DENTSPLY SIRONA Inc

DENTSPLY SIRONA Inc(XRAY)股票分析

$8.870

+0.474 (+5.34%)收盘时

Loading chart…
最高
8.900
开盘
8.470
成交量加权均价
8.73
成交量
6.14M
市值
5.25B
最低
8.430
成交额
53.64M
企业价值/息税折旧摊销前利润(TTM)
5.49

DENTSPLY SIRONA Inc. is a diversified manufacturer of professional dental products and technologies. It develops, manufactures, and markets comprehensive solutions offering dental and oral health products, as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of the Company's value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and digital orthodontic solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.

AI 分析 of DENTSPLY SIRONA Inc (XRAY)

持有

DENTSPLY SIRONA Inc (XRAY) is currently priced at $8.57, which is significantly below the analyst price targets ranging from $10 to $15. However, the stock has seen a year-to-date decline of 23.96% and a 1-year change of -33.72%, indicating ongoing struggles. The RSI is at 42.278, suggesting it is nearing oversold territory, but the MACD indicates bearish momentum. The forward P/E ratio is 6.33, which may suggest undervaluation, yet the company has reported mixed earnings with a gross margin of 54.90% in Q2 2026, showing some operational resilience. The main risk is the negative net income trend, with a net loss of $10 million in Q1 2026 and $37 million in Q2 2026, which could impact future performance.

分析师评级(13)

上行空间 +47.01%
买入
8 买入
4 持有
1 卖出
当前: 8.87
最低
12.00
平均
13.04
最高
17.00

Piper Sandler

2026-10-09

目标价

$12

中性

BMO Capital

2026-09-17

目标价

$10

Market Perform

Barclays

2026-08-24

目标价

$11

减持

Barrington

2026-08-10

目标价

$15

跑赢大盘

BMO Capital

2026-08-07

目标价

$13

Market Perform

估值指标

DENTSPLY SIRONA Inc(XRAY)当前预期市盈率为 6.33,5 年平均预期市盈率为 13.75。

预期市盈率

低估
5 年均值 P/E
13.75
当前P/E
6.33
高估
19.25
低估
8.24

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
5.03
当前EV/EBITDA
5.49
高估
31.40
低估
-21.35

预期市销率

低估
5 年均值 P/S
1.48
当前P/S
0.46
高估
2.19
低估
0.78

Alphio AI 对 XRAY 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%XRAY

$17.73

情景价格

基

基准

基准 · 50%XRAY

$16.62

情景价格

悲

悲观

悲观 · 25%XRAY

$14.22

情景价格

持有 XRAY 的大户

S

Southpoint Capital Advisors LP

+ 持有XRAY

+2.96%

3个月收益率

C

Cooke & Bieler, L.P.

+ 持有XRAY

-0.79%

3个月收益率

A

Ariel Investments, LLC

+ 持有XRAY

-1.96%

3个月收益率

P

Paradigm Capital Management, Inc.

+ 持有XRAY

-20.64%

3个月收益率

事件时间线

2026-08-06 (ET)

16:30:00

Company Maintains FY26 Revenue Outlook of $3.5B-$3.6B

2026-07-28 (ET)

09:30:00

Dentsply Sirona Expands Partnership with Medline Sinclair

2026-06-11 (ET)

09:30:00

Dentsply Sirona Appoints John Fortson as CFO

2026-05-05 (ET)

16:20:00

Dentsply Sirona Reports Q1 Revenue of $880M

16:20:00

Company Maintains FY26 Revenue Outlook of $3.5B-$3.6B

资讯

XRAY 常见问题 —— 由 Alphio AI 解答

DENTSPLY SIRONA Inc. is a diversified manufacturer of professional dental products and technologies. It develops, manufactures, and markets comprehensive solutions offering dental and oral health products, as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of the Company's value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and digital orthodontic solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management. It operates in the Healthcare sector (DENTAL EQUIPMENT & SUPPLIES industry).

DENTSPLY SIRONA Inc (XRAY) is currently priced at $8.57, which is significantly below the analyst price targets ranging from $10 to $15. However, the stock has seen a year-to-date decline of 23.96% and a 1-year change of -33.72%, indicating ongoing struggles. The RSI is at 42.278, suggesting it is nearing oversold territory, but the MACD indicates bearish momentum. The forward P/E ratio is 6.33, which may suggest undervaluation, yet the company has reported mixed earnings with a gross margin of 54.90% in Q2 2026, showing some operational resilience. The main risk is the negative net income trend, with a net loss of $10 million in Q1 2026 and $37 million in Q2 2026, which could impact future performance.

13 analysts cover XRAY: 8 rate it Buy, 4 Hold and 1 Sell. The average price target is 13.04.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易